Company overview
PulpFixin develops sustainable, paper-based alternatives to single-use plastics for life science and pharmaceutical labs, including cryogenic storage boxes, automation pipet tip racks, and tube racks that are 100% compostable, recyclable, and biodegradable. These products withstand extreme conditions like liquid nitrogen at -196°C and integrate with systems such as Agilent Bravo without modifications. They target plastic waste reduction in liquid handling, sample storage, and inventory management workflows.
Pulp Fixin is listed in the NovaPharmaNews Supplier Hub in the life-science supply chain serving United States & Americas. Core focus areas include compostable labware, sustainable pipet racks, cryogenic storage boxes, biotech lab plastics, pharma sample storage.
Structured facts
- Website
- https://www.pulpfixin.us
- Markets served
- United States & Americas
- Keywords
- compostable labware, sustainable pipet racks, cryogenic storage boxes, biotech lab plastics, pharma sample storage
Products & technologies
Markets served
Company timeline
- — Profile published on NovaPharmaNews
Frequently asked questions
- What lab products does PulpFixin offer for pharmaceutical and biotech labs?
- Core products include cryogenic storage boxes, automation pipet tip racks for Agilent Bravo, tube racks, pipette tip trays, AutoSleeve tube adapters, and 2D AutoBox sample storage systems, all as direct replacements for plastic consumables.
- Are PulpFixin products compatible with standard lab equipment and regulatory standards?
- Yes, products fit standard freezer racks, work with automated liquid handlers like Agilent Bravo without modifications, and are certified to ASTM D6400 composting standards, tested for liquid nitrogen and freeze-thaw cycling.
- What geographies does PulpFixin serve and are custom solutions available?
- PulpFixin is US-based with distribution partnerships in the UK and Europe via Wildcat Laboratory Solutions; custom sizes and designs are available for specific lab needs.
Related editorial coverage
- $2M Gene Therapy Cures Need a Financing Model
- A Secure And Intelligent Drug Delivery Model Integrating Neural Networks With Blockchain
- AACR 2024: Daily Oncology Research Roundup
- AACR 2024: Oncology News & Key Takeaways - Day 1
- AACR 2024: Oncology Research Highlights - Day 1 Roundup
- AACR 2026: AI Pathology & Oncolytic Virus Spark Interest
Explore lab tools and QA/QC resources for R&D teams.
